 patients; (2) is CEA recommended over transfemoral CAS for low
surgical risk patients with symptomatic carotid artery stenosis of >50%; (3) the timing of carotid intervention for patients
presenting with acute stroke; (4) screening for carotid artery stenosis in asymptomatic patients; and (5) the optimal
sequence of intervention for patients with combined carotid and coronary artery disease.
A separate implementation document will address